Participants 101 186 7
Fifty-two patients with severe rheumatoid arthritis (RA) from four Australian centres
Participants 927 1138 3
Seven CSA recipients (three gastrointestinal symptoms, two neurological symptoms, two other) and 12 AZA recipients (six gastrointestinal symptoms, four inefficacy, two other) withdrew from treatment prematurely.
Participants 1336 1370 4
severely affected patients with RA
